Research Groups and R&D Platforms: Basic research

Research Group:
Melanocortin and endocannabinoid systems as novel therapeutic targets in atherosclerosis

Petteri Rinne
pperin[at]utu.fi

Department of Pharmacology, Drug development and Therapeutics,
University of Turku

Petteri Rinne

Melanocortin and endocannabinoid systems as novel therapeutic targets in atherosclerosis

Basic research, Biomedicine, Cardiovascular diseases, Disease models, Drug delivery, Drug target, Imaging, Immunology, Inflammation, Medicinal chemistry, Metabolic diseases, Pharmacology, Physiology, Receptor, Signaling, Target discovery, Ultrasound imaging

Research Group:
Cell fate – from molecular understanding to control

Cecilia Sahlgren
cecilia.sahlgren[at]abo.fi, cecilia.sahlgren[at]bioscience.fi

Turku Bioscience and
Faculty of Science and Engineering,
Åbo Aakdemi University

Cecilia Sahlgren

Cell fate

The Cell Fate Lab

Atomic-force microscopy, Basic research, Biochemistry, Biomarker, Biotechnology, Breast cancer, Cancer, Cardiovascular diseases, Data mining, Developmental disorders, Diagnostics, Disease models, Drug delivery, Drug target, Imaging, Imaging software, In Vivo Diagnostics, Molecular Cell Biology, Molecular modelling, Personalized medicine, PET, Proteomics, Receptor, Signaling, Super-resolution imaging, Target discovery

Research Group:
Molecular imaging of atherosclerosis and heart failure

Antti Saraste
antti.saraste[at]utu.fi

Heart Center and PET Center,
University of Turku

Antti Saraste

Basic research, Biomarker, Cardiovascular diseases, Clinical Medicine, Diabetes, Disease models, Imaging, In Vivo Diagnostics, Inflammation, PET, Target discovery, Ultrasound imaging

Research Group:
Alpha2-Adrenoceptors as targets for drug development

Mika Scheinin
mschein[at]utu.fi

University of Turku, Turku University Hospital and CRST Oy

Mika Scheinin

Alpha2-Adrenoceptors as targets for drug development

Positron emission tomography (PET) imaging in CNS drug research

www.crst.fi

Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery

Research Group:
Molecular determinants of picornaviral disease

Petri Susi
pesusi[at]utu.fi

Department of Virology,
University of Turku

Petri Susi

https://www.biocity.turku.fi/wp-content/uploads/2017/06/Susi.pdf

airopico

Asthma, Basic research, Bioinformatics, Biomarker, Biotechnology, Cancer, Electron microscopy, Epidemiology, Genomics, Imaging, Imaging software, In Vitro Diagnostics, Infection, Molecular Biology, Molecular Cell Biology, Molecular modelling, Next-generation sequencing, Point of care, Target discovery, Virology

Research Group:
Keratins as modulators of epithelial stress responses and regeneration

Diana Toivola
dtoivola[at]abo.fi

Cell Biology, Faculty of Science and Engineering,
Åbo Akademi University

Diana Toivola

Toivola Lab

https://www.biocity.turku.fi/wp-content/uploads/2017/06/Toivola.pdf

TCDM Intestinal Diseases Unit

Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biotechnology, Cancer, Colorectal cancer, Data mining, Diabetes, Disease models, Drug delivery, Electron microscopy, Endocrinology, Formulation, Imaging, Imaging software, Immunology, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular Biology, Molecular Cell Biology, Nanoparticles, Obesity, Pathology, PET, Physiology, Proteomics, Receptor, Screening, Signaling, Super-resolution imaging, Target discovery, Ultrasound imaging